Navin Fluorine International Limited · NSE:NAVINFLUOR

Navin Fluorine International — FY2018 Earnings Presentation

23 slides from Navin Fluorine International's earnings presentation, Jul 29, 2018

  1. Slide 1: Navin Fluorine International Limited Result Update Presentation FY18

    Navin Fluorine International Limited Result Update Presentation FY18

  2. Slide 2: Safe Harbor

    Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Navin Fluorine International Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe

  3. Slide 3: Standalone Financial Highlights – Quarter 4

    Standalone Financial Highlights – Quarter 4 Revenue from Operations (Rs. Crs)^ Operating EBITDA (Rs. Crs) +5% +22% 198 208 46 38 Q4 FY17** Q4 FY18 Q4 FY17** Q4 FY18 Operating PBT (Rs. Crs) Margins (%) +41% Operating EBITDA Margin Operating PBT Margin 38 22.1% 27 19.0% 18.2% 13.6% Q4 FY17** Q4 FY18 Q

  4. Slide 4: Standalone Financial Highlights – Full Year

    Standalone Financial Highlights – Full Year* Revenue from Operations (Rs. Crs)^ Operating EBITDA (Rs. Crs) +26% +41% 873 211 695 150 FY17** FY18** FY17** FY18** Operating PBT (Rs. Crs) Margins (%) +42% Operating EBITDA Margin Operating PBT Margin 172 24.1% 121 21.6% 19.7% 17.4% FY17** FY18** FY17**

  5. Slide 5: Standalone Profitability Statement [as per Ind AS]

    Standalone Profitability Statement [as per Ind AS] Particulars (Rs. Crs.) Q4 FY18 Q4 FY17** Change % FY18** FY17** Change % Net Revenue from Operations^ 208.4 197.9 5% 873.4 695.1 26% Raw Material 93.7 104.0 384.8 309.9 Employee Expenses 24.1 22.8 90.8 76.6 Other Expenses 44.6 33.4 187.1 158.6 Opera

  6. Slide 6: Standalone Balance Sheet [as per Ind AS]

    Standalone Balance Sheet [as per Ind AS] ASSETS (Rs. Crs.) 31-Mar-18 31-Mar-17 EQUITY AND LIABILITIES (Rs. Crs.) 31-Mar-18 31-Mar-17 Non-current assets 685.9 691.3 Property, Plant and Equipment 275.5 410.5 EQUITY 970.0 823.5 Capital work-in-progress 20.1 16.8 Equity Share Capital 9.9 9.8 Investment

  7. Slide 7: Annexure

    Annexure Sales for the Quarter ended 31st March 2018 is net of Goods and Services Tax (GST), however sales till period ended 31st March 2017 and other comprehensive periods are gross of Excise duty. The Net Revenue from Operations (Net of GST/Excise Duty) as applicable are as stated below: Standalon

  8. Slide 8: Business Units Performance: Revenue Break-up

    Business Units Performance : Revenue Break-up* Refrigerants (Rs. Crs) Inorganic Fluorides (Rs. Crs) +14% +23% 242 148 211 120 65% +29% +17% 68% 87% 43 92% Domestic 57 66 Domestic 33 Exports 61% 62% 32% 35% Exports 87% 89% 13% 39% 38% 11% 13% 8% Q4 FY17 Q4 FY18 FY17 FY18 Q4 FY17 Q4 FY18 FY17 FY18 Spe

  9. Slide 9: Standalone Revenue Mix: Business Unit Wise

    Standalone Revenue Mix : Business Unit Wise* 16% 19% 18% 25% 34% 29% 33% 28% 18% 21% 18% 18% 31% 32% 31% 30% Q4 FY17** Q4 FY18 FY17** FY18** CRAMS Specialty Chemicals Inorganic Fluorides Refrigerant Gases Note: (a) Revenue is Net of Excise Duty / GST * as per Ind AS financials 9 ** Excludes Revenue

  10. Slide 10: Key Highlights for FY18

    Key Highlights for FY18 Sale of Undertaking at Dahej, Gujarat: ❖ With the effect from December 1, 2017 the business relating to the manufacture and sale of Specialty Fluorochemicals being conducted at Dahej is being transferred to CCPL (Joint Venture Company incorporated pursuant to the said Joint V

  11. Slide 11: Annual Financial Performance

    Annual Financial Performance# Refrigerants Increasing demands for cooling Traction in Key product Inorganic Fluorides solutions & as feedstock for portfolios & Customer segments Pharmaceutical industry to drive 148 211 242 120 long term growth 30% 18% FY17 FY18 FY17 FY18 Revenue Break-up FY18 CRAMS*

  12. Slide 12: Rising up Fluorine Value-Pyramid…

    Rising up Fluorine Value-Pyramid… FY11 – Revenue % FY18 – Revenue % Commenced CRAMS business in 2011 CRAMS – 0% CRAMS* – 25% Commenced Specialty Chemicals in Specialty Specialty 2000 Chemicals – 27% Chemicals –28% Inorganic Fluorides & Refrigerants (Incl. Refrigerants – Refrigerants are CER) –55% 30

  13. Slide 13: …Strategy Yielding Results

    …Strategy Yielding Results Return on Net Worth (%) Return on Capital Employed (%) 18% 27% 16% 22% 14% 18% 10% 9% 9% 12% 11% 11% FY13** FY14** FY15** FY16** FY17^ FY18^ FY13** FY14** FY15** FY16** FY17^ FY18^ * Standalone Results ** - Calculated based on I GAAP Financials 13 ^ - Calculated based on I

  14. Slide 14: Consistent Dividend Performance

    Consistent Dividend Performance Dividend as % of Face Value Robust Dividend Payout Special 500% ✓ Continuous Dividend since last 10 years Final Interim 150% ✓ Special Dividend of Rs. 60.00 per share 315% in FY12 75% 180% 210% ✓ Special Divided of 75% in FY17 150% 150% 150% 160% 160% 130% 140% 110% 7

  15. Slide 15: Consolidated Profitability Statement [as per Ind AS]

    Consolidated Profitability Statement [as per Ind AS] Particulars (Rs. Crs.) FY18** FY17** Change % Net Revenue from Operations^ 912.7 741.5 23% Raw Material 402.3 327.2 Employee Expenses 110.5 91.8 Other Expenses 184.9 163.7 Operating EBITDA 215.0 158.8 35% Operating EBITDA Margin 23.6% 21.4% Intere

  16. Slide 16: Consolidated Balance Sheet [as per Ind AS]

    Consolidated Balance Sheet [as per Ind AS] ASSETS (Rs. Crs.) 31-Mar-18 31-Mar-17 EQUITY AND LIABILITIES (Rs. Crs.) 31-Mar-18 31-Mar-17 Non-current assets 690.5 710.0 Property, Plant and Equipment 281.8 415.0 EQUITY 983.5 835.2 Capital work-in-progress 20.1 16.8 Equity Share Capital 9.9 9.8 Investmen

  17. Slide 17: Business Overview

    Responsible Care” Business Overview e PADMANABH Ni MAFATLAL GROUP

  18. Slide 18: Overview

    Overview Built “India’s only plant with high pressure fluorination capabilities with cGMP compliance” for Largest Integrated Specialty Fluorochemical CRAMS Business Company in India Manufacturing plants strategically Over 50 years of expertise in Handling Fluorine located closer to major ports Stron

  19. Slide 19: Business Units (BU) – Standalone

    Business Units (BU) – Standalone CRAMS 03 • Leveraging our proven skills in Fluorination Chemistry • CRAMS for custom chemical syntheses of fluorinated compounds for the pharmaceuticals, agro chemicals and speciality chemicals industries 02 Specialty Chemicals • Large Scale Manufacture of Specialty

  20. Slide 20: Clients across the Globe

    Lj Clients across the Globe Ne. . . CLARIANT= ico) Bayer syngenta (eS) Bayer CropScience we tee W Novartis . LUPIN [8] HETERO Y Dr.Reppy's LIFE. RESEARCH . HOPE | | N e PADMANABH MAFATLAL GROUP

  21. Slide 21: Key Strengths

    Key Strengths Fluorination Capabilities In-house R&D ✓ Pioneered Manufacturing of ✓ State-of-the-art R&D centre – Navin Refrigerant Gases in India Research Innovation Centre at Surat ✓ Over 45 years of experience in ✓ DSIR approved R&D Centre handling Fluorine ✓ Supports in product addition & ✓ Exte

  22. Slide 22: Growth driven by Every Business Unit

    Growth driven by Every Business Unit CRAMS ✓ Business progression from Contract research to contract manufacturing ✓ Manufacturing facility commercially operational Specialty Chemicals ✓ Introduction of new high value added molecules in portfolio ✓ Entry into newer geographies Inorganic Fluorides ✓

  23. Slide 23: Contact

    Contact For further information, please contact: Company : Investor Relations Advisors : Navin Fluorine International Ltd. Strategic Growth Advisors Pvt. Ltd. CIN : L24110MH1998PLC115499 CIN : U74140MH2010PTC204285 Mr. Sitendu Nagchaudhuri Ms. Payal Dave / Mr Jigar Kavaiya Chief Financial Officer 98

Navin Fluorine International — FY2018 Earnings Presentation on 6ix